Scientists launch deep dive into IBD to uncover hidden clues
NCT ID NCT07619547
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 34 times
Summary
This study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to find new biomarkers that could predict disease activity or response to therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could identify new biomarkers to predict disease flares or treatment response, guiding future therapies.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to immediate clinical changes, and findings may not apply to all IBD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. scope: a gentler way to spot pouch inflammation?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can we predict how kids with IBD will respond to treatment?
- Could IBD medications during pregnancy shape a Child's development?
- AI reads scans to forecast Crohn's complications
- Can stem cell vesicles heal Crohn's fistulas?